The Greater Cannabis Co., Inc. engages in the business of cannabis related investment and development opportunities through online retail store, direct equity investments, joint ventures, licensing agreements, or acquisitions. The company is headquartered in Baltimore, Maryland and currently employs 1 full-time employees. The company went IPO on 2018-07-09. The firm is involved in additional research and development of cannabinoid-based therapeutics that reduce disruptive symptoms in patients suffering from neuropsychiatric disorders. The firm also focuses on developing new formulations around cannabinoid therapeutics. Its wholly owned subsidiary is Biocanrx, Inc.
根據最新的財務報表(Form-10K),Greater Cannabis Company Inc 的總資產為 $0,淨損失為 $0
GCAN 的關鍵財務比率是什麼?
Greater Cannabis Company Inc 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
Greater Cannabis Company Inc 的收入按細分市場或地理位置如何劃分?
Greater Cannabis Company Inc 最大收入來源為 Business & Administrations,在最近的收益報告中收入為 11,411,000,000。就地區而言,United States 是 Greater Cannabis Company Inc 的主要市場,收入為 10,568,000,000。